Subsequently Closed C$10.7 Million in New Capital in May 2024
Eliminated C$11.7
Million in Convertible Debt
SAN
JOSE, Calif., May 30, 2024
/CNW/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc.
("Spectra7" or the "Company"), a leader in
high-performance analog semiconductors for broadband connectivity
markets, such as AI networks, hyperscale data centers, and AR/VR,
today announced its financial results for the three months ended
March 31, 2024. A copy of the interim
consolidated financial statements for the three months ended
March 31, 2024, and the corresponding
management's discussion and analysis (the "MD&A") will
be available under the Company's profile on www.sedarplus.ca.
Unless otherwise indicated, all dollar amounts in this press
release are expressed in US dollars.
First quarter 2024 financial highlights
- First quarter 2024 revenue was $0.8
million, increased from $0.3
million in the fourth quarter 2023 and decreased from
$3.1 million in the first quarter
2023.
- Gross margin1 was 41%, compared to 57% in the
preceding quarter and 63% in the prior year first quarter.
- Non-IFRS operating expenses2 were $2.1 million, decreased from $3.5 million in the fourth quarter 2023 and
$2.2 million in the first quarter
2023.
- Basic and diluted loss per share for the first quarter 2024 was
$(0.06), compared with a basic and
diluted loss per share of $(0.11) in
the fourth quarter 2023 and $(0.03)
in the first quarter 2023.
- EBITDA3 loss for the first quarter was $1.4 million, compared with an EBITDA loss of
$3.2M for the fourth quarter 2023 and
an EBITDA loss of $70,000 in the
first quarter 2023.
Subsequent to the first quarter end, the Company completed a
non-brokered private placement of units for C$10.7 million in gross proceeds. Additionally,
the Company amended its C$11.7
million of existing debentures to provide the Company with
the right to convert such debentures into equity securities at its
option at any time prior to maturity. The Company effected the
forced conversion of the debentures on May
15, 2024, effectively eliminating the Company's long-term
debt.
Spectra7 remains focused on advancing to commercial orders from
top global datacenter customers for its active copper cable
products, expected in the second half of 2024.4
"We are pleased to have strengthened our balance sheet and
eliminated our long term debt in support of our growth plans," said
Raouf Halim, Chief Executive
Officer.
NOTES:
1 Gross margin is a non-GAAP measure which is
computed as revenue less cost of sales divided by revenue. Refer to
"Revenue and Gross Margin" in the MD&A and the table below, for
reconciliation to measures reported in the Company's interim
financial statements.
The table below sets forth the details of revenue and gross
margin for the three months ended March 31,
2024 and March 31, 2023.
|
Three Months Ended
March 31,
|
|
(In
thousands)
|
|
2024
|
|
2023
|
|
Change
|
|
|
$
|
|
$
|
|
$
|
%
|
Revenue
|
816
|
|
3,134
|
|
(2,318)
|
(74 %)
|
Cost of
sales
|
483
|
|
1,172
|
|
(689)
|
(59 %)
|
Gross profit
|
333
|
|
1,963
|
|
(1,629)
|
(83 %)
|
Gross margin
%
|
41 %
|
|
63 %
|
|
(22 %)
|
|
|
|
|
|
|
|
|
2 Non-IFRS operating expenses is a non-GAAP
measure which includes research and development, sales and
marketing, general and administrative expenses and depreciation and
amortization for capital equipment and right-of-use assets and
excludes share-based compensation expense, non-recurring
termination costs, interest and related financing costs, change in
fair value of warrant liabilities, foreign exchange gain/loss and
gain/loss from property and equipment disposal. Refer to "Non-GAAP
Measures" in the MD&A and the table below for reconciliation to
measures reported in the Company's interim financial
statements.
|
|
in
thousands
|
|
|
2022
|
|
2023
|
|
2024
|
|
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
|
|
$
|
$
|
$
|
|
$
|
$
|
$
|
$
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses -
IFRS
|
|
3,331
|
2,936
|
3,210
|
|
3,053
|
3,330
|
3,086
|
4,479
|
|
2,575
|
Share‑based
compensation
|
|
646
|
567
|
469
|
|
541
|
486
|
288
|
334
|
|
182
|
Interest on lease
obligation of right-of-use assets
|
|
5
|
4
|
3
|
|
1
|
4
|
4
|
3
|
|
1
|
Accretion
expense
|
|
389
|
463
|
425
|
|
370
|
389
|
411
|
493
|
|
538
|
Other income
|
|
(12)
|
-
|
-
|
|
-
|
(12)
|
(30)
|
(9)
|
|
-
|
Foreign exchange
gain
|
|
57
|
(9)
|
354
|
|
(72)
|
57
|
(110)
|
143
|
|
(211)
|
Non-IFRS operating
expenses
|
|
2,246
|
1,911
|
1,959
|
|
2,212
|
2,407
|
2,523
|
3,515
|
|
2,065
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in
thousands
|
|
|
2022
|
|
2023
|
|
2024
|
|
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
|
|
$
|
$
|
$
|
|
$
|
$
|
$
|
$
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development, net of investment
tax credits and including amortization of licenses
|
|
1,158
|
985
|
928
|
|
995
|
1,195
|
1,409
|
1,154
|
|
1,040
|
Sales and
marketing
|
|
258
|
224
|
280
|
|
269
|
252
|
271
|
325
|
|
279
|
General and
administrative
|
|
875
|
635
|
684
|
|
881
|
891
|
762
|
1,947
|
|
657
|
Depreciation of
right-of-use assets
|
|
113
|
60
|
60
|
|
60
|
60
|
60
|
60
|
|
60
|
Depreciation of
property and equipment
|
|
10
|
7
|
8
|
|
8
|
8
|
21
|
28
|
|
28
|
Non-IFRS operating
expenses
|
|
2,414
|
1,911
|
1,959
|
|
2,212
|
2,407
|
2,523
|
3,515
|
|
2,065
|
3 EBITDA or earnings before interest, tax,
depreciation, and amortization is a non-GAAP measure. EBITDA
excludes share-based compensation, amortization, depreciation,
interest, and tax expenses. Refer to "Non-GAAP Measures" in the
MD&A and the table below for reconciliation to measures
reported in the Company's interim financial
statements.
|
|
in
thousands
|
|
|
2022
|
|
2023
|
|
2024
|
|
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
Jun
30
|
Sep
30
|
Dec
31
|
|
Mar
31
|
|
|
$
|
$
|
$
|
|
$
|
$
|
$
|
$
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
(1,586)
|
(1,461)
|
(1,231)
|
|
(1,090)
|
(1,275)
|
(1,500)
|
(4,315)
|
|
(2,242)
|
Depreciation of
right-of-use assets
|
|
113
|
60
|
60
|
|
60
|
60
|
60
|
60
|
|
60
|
Depreciation of
property and equipment
|
|
10
|
7
|
8
|
|
8
|
8
|
21
|
28
|
|
28
|
Depreciation expense -
COGS
|
|
18
|
31
|
35
|
|
35
|
30
|
31
|
31
|
|
32
|
Amortization -
intangible assets
|
|
145
|
137
|
55
|
|
76
|
105
|
90
|
179
|
|
167
|
Share-based
compensation
|
|
646
|
567
|
469
|
|
541
|
486
|
288
|
334
|
|
182
|
Interest on lease
obligation of right-of-use assets
|
|
5
|
4
|
3
|
|
1
|
4
|
4
|
3
|
|
1
|
Accretion
expense
|
|
232
|
463
|
425
|
|
370
|
389
|
411
|
493
|
|
538
|
Other income
|
|
-
|
-
|
-
|
|
-
|
(12)
|
(30)
|
(9)
|
|
-
|
Foreign Tax
|
|
-
|
-
|
(216)
|
|
-
|
-
|
-
|
(119)
|
|
-
|
Foreign exchange
gain
|
|
34
|
(9)
|
354
|
|
(72)
|
57
|
(110)
|
143
|
|
(211)
|
Extingushment of
original convertible debt
|
|
-
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
Other income
|
|
(217)
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
EBITDA
|
|
(600)
|
(201)
|
(38)
|
|
(70)
|
(148)
|
(734)
|
(3,172)
|
|
(1,445)
|
4 This is forward-looking information and is based on
a number of assumptions. See "Cautionary Notes," below.
ABOUT SPECTRA7 MICROSYSTEMS INC.
Spectra7 Microsystems Inc. is a high-performance analog
semiconductor company delivering unprecedented bandwidth, speed and
resolution to enable disruptive industrial design for leading
electronics manufacturers in virtual reality, augmented reality,
mixed reality, data centers and other connectivity markets.
Spectra7 is based in San Jose,
California with a design center in Cork, Ireland and a technical support location
in Dongguan, China. For more
information, please visit www.spectra7.com.
Neither the TSX Venture Exchange nor its regulation services
provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
CAUTIONARY NOTES
Certain statements contained in this press release constitute
"forward-looking statements". All statements other than statements
of historical fact contained in this press release, including,
without limitation, the Company's anticipated increase in
commercial orders in the second half of 2024 for its datacenter
products, which is dependent on the success of various sampling
efforts currently underway; and the Company's strategy, plans,
objectives, goals and targets, and any statements preceded by,
followed by or that include the words "believe", "expect", "aim",
"intend", "plan", "continue", "will", "may", "would", "anticipate",
"estimate", "forecast", "predict", "project", "seek", "should" or
similar expressions or the negative thereof, are forward-looking
statements. These statements are not historical facts but instead
represent only the Company's expectations, estimates and
projections regarding future events. These statements are not
guarantees of future performance and involve assumptions, risks and
uncertainties that are difficult to predict. Therefore, actual
results may differ materially from what is expressed, implied or
forecasted in such forward-looking statements. Additional factors
that could cause actual results, performance or achievements to
differ materially include, but are not limited to, the risk factors
discussed in the Company's management's discussion and analysis for
the year ended December 31, 2023.
Management provides forward-looking statements because it believes
they provide useful information to investors when considering their
investment objectives and cautions investors not to place undue
reliance on forward-looking information. Consequently, all of the
forward-looking statements made in this press release are qualified
by these cautionary statements and other cautionary statements or
factors contained herein, and there can be no assurance that the
actual results or developments will be realized or, even if
substantially realized, that they will have the expected
consequences to, or effects on, the Company. These forward-looking
statements are made as of the date of this press release and the
Company assumes no obligation to update or revise them to reflect
subsequent information, events or circumstances or otherwise,
except as required by law.
For more information, please contact:
Matt Kreps, Managing Director
Darrow Associates Investor Relations
mkreps@darrowir.com
214-597-8200
Spectra7 Microsystems Inc.
Dave Mier
Interim Chief Financial Officer
925-858-7011
ir@spectra7.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/spectra7-announces-financial-results-for-first-quarter-2024-302159933.html
SOURCE Spectra7 Microsystems Inc.